Am Sciences Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Out of Business

Am Sciences General Information

Description

Developer of therapeutic compounds designed to help in the treatment of Hepatitis B. The company's compounds develop AMS-I series compounds as capsid formation inhibitors which have been shown to dramatically improve the functional cure rate of chronic hepatitis b, enabling affected patients to alleviate the symptoms and prevent the disease from getting worse.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Skypolis Complex Na-775, 135, Misagangbyeonhangang-ro
  • Hanam-si, Gyeonggi-do
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Skypolis Complex Na-775, 135, Misagangbyeonhangang-ro
  • Hanam-si, Gyeonggi-do
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Am Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 02-May-2025 Completed Out of Business
1. Early Stage VC 01-Jan-2018 Completed Generating Revenue
To view Am Sciences’s complete valuation and funding history, request access »

Am Sciences Patents

Am Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024249867-A1 Compounds for treating fibrotic diseases Inactive 02-Jun-2023
AU-2022363172-A1 Novel capsid assembly inhibitors Inactive 12-Oct-2021
EP-4416150-A1 Novel capsid assembly inhibitors Inactive 12-Oct-2021
US-20250235462-A1 Novel capsid assembly inhibitors Pending 12-Oct-2021
WO-2023063697-A1 Novel capsid assembly inhibitors Inactive 12-Oct-2021 A61K31/501
To view Am Sciences’s complete patent history, request access »

Am Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Am Sciences FAQs

  • When was Am Sciences founded?

    Am Sciences was founded in 2016.

  • Where is Am Sciences headquartered?

    Am Sciences is headquartered in Hanam-si, South Korea.

  • What is the size of Am Sciences?

    Am Sciences has 9 total employees.

  • What industry is Am Sciences in?

    Am Sciences’s primary industry is Drug Discovery.

  • Is Am Sciences a private or public company?

    Am Sciences is a Private company.

  • What is Am Sciences’s current revenue?

    The current revenue for Am Sciences is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process